|
Cardiovascular Pharmacology
Citations 471-480 of 640 total displayed.
|
Past content
(since Jan 1999):
|
- Scientific Contributions
ACE Inhibition Versus Angiotensin Type 1 Receptor Antagonism. Differential Effects on PAI-1 Over Time
- Nancy J. Brown, Sandeep Kumar, Corrie A. Painter, and Douglas E. Vaughan
Hypertension published October 28, 2002, doi:10.1161/01.HYP.0000040264.15961.48
[Abstract]
- Scientific Contributions
Endothelin-Converting Enzyme Inhibition
Ameliorates Angiotensin II-Induced Cardiac
Damage
- Dominik N. Muller, Alexander Mullally, Ralf Dechend, Joon-Keun Park, Anette Fiebeler, Bernhard Pilz, Bernd-Michael Löffler, Denise Blum-Kaelin, Stefan Masur, Henrietta Dehmlow, Johannes D. Aebi, Hermann Haller, and Friedrich C. Luft
Hypertension published October 21, 2002, doi:10.1161/01.HYP.0000039748.88581.A0
[Abstract]
- Scientific Contributions
Drug Effects on Aldosterone/Plasma
Renin Activity Ratio in Primary Aldosteronism
- Paolo Mulatero, Franco Rabbia, Alberto Milan, Cristina Paglieri, Fulvio Morello, Livio Chiandussi, and Franco Veglio
Hypertension published October 21, 2002, doi:10.1161/01.HYP.0000038478.59760.41
[Abstract]
- Scientific Contributions
Effects of Doxazosin and Propranolol on A2A Adenosine Receptors in Essential Hypertension
- Katia Varani, Roberto Manfredini, Valeria Iannotta, Cecilia Pancaldi, Elena Cattabriga, Canan Uluoglu, Pier Andrea Borea, and Francesco Portaluppi
Hypertension published October 14, 2002, doi:10.1161/01.HYP.0000039505.79741.15
[Abstract]
- Scientific Contributions
Long-Term Adrenomedullin Administration in Experimental Heart Failure
- Miriam T. Rademaker, Chris J. Charles, Eric A. Espiner, M. Gary Nicholls, and A. Mark Richards
Hypertension published October 7, 2002, doi:10.1161/01.HYP.0000037132.90640.26
[Abstract]
- Scientific Contributions
NAD(P)H Oxidase Inhibition Improves Endothelial Function in Rat and Human Blood Vessels
- Carlene A. Hamilton, M. Julia Brosnan, Sammy Al-Benna, Geoffrey Berg, and Anna F. Dominiczak
Hypertension published October 7, 2002, doi:10.1161/01.HYP.0000037063.90643.0B
[Abstract]
- Scientific Contributions
Acute Antihypertrophic Actions of Bradykinin in the Rat Heart: Importance of Cyclic GMP
- Anke C. Rosenkranz, Sally G. Hood, Robyn L. Woods, Gregory J. Dusting, and Rebecca H. Ritchie
Hypertension 2002;40:498-503; published online before print as doi:10.1161/01.HYP.0000032854.74042.CF
[Abstract]
[Full text]
- Scientific Contributions
Angiotensin II AT1 Receptor Antagonists Inhibit Platelet Adhesion and Aggregation by Nitric Oxide Release
- Leszek Kalinowski, Tomasz Matys, Ewa Chabielska, Wlodzimierz Buczko, and Tadeusz Malinski
Hypertension 2002;40:521-527; published online before print as doi:10.1161/01.HYP.0000034745.98129.EC
[Abstract]
[Full text]
- Scientific Contributions
Role of Cyclooxygenase-2 in the Prolonged Regulation of Renal Function
- Francisco Roig, Maria T. Llinás, Ruth López, and F. Javier Salazar
Hypertension published September 30, 2002, doi:10.1161/01.HYP.0000036451.76323.29
[Abstract]
- Scientific Contributions
Interaction of Sildenafil With cAMP-Mediated Vasodilation In Vivo
- Christoph Schalcher, Karin Schad, Hans Peter Brunner-La Rocca, Ruth Schindler, Erwin Oechslin, Christoph Scharf, Gabor Suetsch, Osmund Bertel, and Wolfgang Kiowski
Hypertension published September 23, 2002, doi:10.1161/01.HYP.0000036027.71527.3E
[Abstract]
|
|